Major investment for respiratory diseases completed
Major investment for respiratory diseases completed105 million euros invested into expansion of production facilities in Ingelheim and DortmundEuropean launches of next-generation inhaler kicked off
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Research | Respiratory Medicine